Defined Benefit (Pension) · DOL Form 5500 · 2023
Astrazeneca Pharmaceuticals LP Pension Plan
Data updated 2026-08-25
- N/A
- Total assets —
- 478
- Participants Below avg headcount
Official DOL plan name: Astrazeneca Defined Benefit Pension Plan · Sponsored by Astrazeneca Pharmaceuticals LP · Delaware · Manufacturing
N/A in assets, 478 participants
Astrazeneca Pharmaceuticals LP's Astrazeneca Defined Benefit Pension Plan reported N/A in total assets and 478 participants in its 2023 DOL Form 5500 filing. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.
Astrazeneca Pharmaceuticals LP multi-year trail
Astrazeneca Pharmaceuticals LP's plans moved +25.1% in assets from 2022 to 2024; this filing shows Astrazeneca Defined Benefit Pension Plan at N/A / 478 participants.
- -$831M
- reported net income
The plan reported a net loss of $831M for the year, a single-year figure driven by markets and benefit payments, not a measure of plan health.
Astrazeneca Defined Benefit Pension Plan among mid-size filed plans by headcount
Plan-year 2023 Form 5500 filings with a reported participant count, partitioned by headcount band, not by assets. Astrazeneca Defined Benefit Pension Plan sits mid-pack in the medium band (478 participants).
What changed between DOL Form 5500 filings
plan year 2022 → plan year 2023
- Astrazeneca Defined Benefit Pension Plan reported net income fell from -$363M in the plan year 2022 filing to -$831M in the plan year 2023 filing.
- Astrazeneca Defined Benefit Pension Plan reported participants fell from 562 in the plan year 2022 filing to 478 in the plan year 2023 filing.
EBSA filing schedule strip
Filing strip 232967016 · Astrazeneca Pharmaceuticals LP PY 2023 · Defined Benefit (Pension)
Astrazeneca Defined Benefit Pension Plan · N/A · 478
- PHOTO N/A
- PHOTO 478
- PHOTO PY 2023
- PHOTO Defined Benefit (Pension)
- PHOTO near Southern California Floor Covering Pension Trust Fund
- PHOTO -$831M
Stamps derive from this plan's Form 5500 line items (assets, participants, type, EIN, cohort placement) - not a quality rating of the sponsor. Read with Manufacturing retirement plans → · Plans in Delaware →
Astrazeneca Pharmaceuticals LP multi-year asset trail
Sponsor-wide plan assets over time
All Astrazeneca Pharmaceuticals LP plans reported in each filing year
- Latest sponsor-wide plan assets
- $8.7B 25.071382122346026% vs 2022
- 2024 filing year
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 3 | 13,918 | $6.9B |
| 2023 | 3 | 14,269 | $7.6B |
| 2024 | 2 | 17,228 | $8.7B |
Astrazeneca Pharmaceuticals LP filing trail (2023)
| Total Assets (Beginning of Year) | $833M |
|---|---|
| Net Assets (End of Year) | N/A |
| Net Income | -$831M |
| Employer EIN | 232967016 |
| Plan Effective Date | 1976-01-01 |
| Filing Status | FILING RECEIVED |
Nearby Defined Benefit (Pension) Plans in Delaware
Peer Defined Benefit (Pension) plans, same state, same plan type, ranked by total assets.
- Pension and Retirement Plan $11.4B · 2,588
- Christiana Care Health Services, Inc. Retirement Plan $615M · 2,416
- Syngenta Corporation Pension Plan $393M · 957
- Legacy Greyhound Lines, Inc./Amalgamated Transit Union National Local 1700 Retirement Plan $179M · 22
- Bayhealth Medical Center, Inc. Pension Plan $178M · 621
Astrazeneca Defined Benefit Pension Plan's closest out-of-state Defined Benefit (Pension) peers by headcount
Outside Delaware, the nearest Defined Benefit (Pension) by covered participants is Southern California Floor Covering Pension Trust Fund in CA (478 participants; this filing: 478 participants).
Similar participant headcount
Nearest other-state filings by covered participants (478 participants); asset peers above are excluded.
- Southern California Floor Covering Pension Trust Fund (CA) 478 · 0 off
- Arconic Corp. Pension Plan a (PA) 478 · 0 off
- Plumbers & Pipefitters Local 123 Pension Fund (FL) 477 · 1 off
- Century Aluminum Consolidated Retirement Plan (IL) 477 · 1 off
DOL Form 5500 plan year 2023. Asset totals can differ widely at the same headcount; neither axis is a quality rating.